SARS-CoV-2 TrimericS IgG Quantiferon
Device
DiaSorin Inc.
Total Payments
$11,535
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $11,535 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11,535 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SARS-CoV-2 TrimericS IgG Quantiferon Clinical Study | DiaSorin Inc. | $11,535 | 0 |
Top Doctors Receiving Payments for SARS-CoV-2 TrimericS IgG Quantiferon
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Minneapolis, MN | $11,535 | 1 |
Ad
Manufacturing Companies
- DiaSorin Inc. $11,535
Product Information
- Type Device
- Total Payments $11,535
- Total Doctors 0
- Transactions 1
About SARS-CoV-2 TrimericS IgG Quantiferon
SARS-CoV-2 TrimericS IgG Quantiferon is a device associated with $11,535 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..
Payment data is available from 2022 to 2022. In 2022, $11,535 was paid across 1 transactions to 0 doctors.
The most common payment nature for SARS-CoV-2 TrimericS IgG Quantiferon is "Unspecified" ($11,535, 100.0% of total).
SARS-CoV-2 TrimericS IgG Quantiferon is associated with 1 research study, including "SARS-CoV-2 TrimericS IgG Quantiferon Clinical Study" ($11,535).